Jaguar Health, Inc. (JAGX) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Jaguar Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.775 Greetings and welcome to the Jaguar Health Investor Webcast. 00:00:03.775 -- 00:00:07.019 At this time, all participants are in a vision-only mode. 00:00:07.019 -- 00:00:11.104 If anyone should require operator assistance during the conference, please press star 00:00:11.104 -- 00:00:16.030 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:16.030 -- 00:00:19.735 Before I turn the call over to management, I'd like to remind you that management make 00:00:19.735 -- 00:00:24.680 forward-looking statements relating to such matters as continued growth prospects for 00:00:24.680 -- 00:00:30.060 the company, uncertainties regarding market acceptance of products, the impact of competitive 00:00:30.060 -- 00:00:35.326 products and pricing, industry trends, other initiatives including products in the development 00:00:35.326 -- 00:00:40.973 stage which may achieve scientific objectives or meet stringent regulatory requirements. 00:00:40.973 -- 00:00:45.059 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:00:45.059 -- 00:00:50.325 results to differ materially from those contemplated in such forward-looking statements. 00:00:50.325 -- 00:00:54.731 These statements are based on currently available information and management's current 00:00:54.731 -- 00:00:59.599 assumptions, expectations, and projections about future events. 00:00:59.599 -- 00:01:04.045 While management believes its assumptions, expectations, and projections are reasonable 00:01:04.045 -- 00:01:09.212 in view of currently available information, you are cautioned not to place undue reliance 00:01:09.212 -- 00:01:13.838 on these forward-looking statements. The company's actual results may differ mate...